XML 49 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivative Instruments; Fair Value
6 Months Ended
Jun. 30, 2012
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Fair Value [Text Block]

Note 9 - Derivative Instruments; Fair Value

 

The following table represents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2012, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

 

    Amount as of                    
Description   6/30/2012     Level 1     Level 2     Level 3  
                         
Interest Rate Swap 2011   $ (5,000 )   $ -     $ (5,000 )   $ -  
                                 
    $ (5,000 )   $ -     $ (5,000 )   $ -  

 

The Company is exposed to certain market risks including the effect of changes in interest rates. The Company uses derivative instruments to manage financial exposures that occur in the normal course of business. It does not hold or issue derivatives for speculative trading purposes. The Company is exposed to non-performance risk from the counterparties in its derivative instruments. This risk would be limited to any unrealized gains on current positions. To help mitigate this risk, the Company transacts only with counterparties that are rated as investment grade or higher and all counterparties are monitored on a continuous basis. The fair value of the Company’s derivatives reflects this credit risk.

 

On July 1, 2011, we entered into a swap agreement with BMO Capital Markets with respect to $6,780,000 of our loan balances with Harris. This swap agreement limits the Company’s exposure to interest rate fluctuations on the Company’s floating rate loans. The swap agreement has the effect of fixing the interest rate on the loan balances covered by the swap at 4.65% per annum. The swap agreement is a derivative financial instrument and we determine and record the fair market value of the swap agreement each quarter. The value is recorded on the balance sheet of the Company and the amount of the unrealized gain or loss for each period is recorded as interest income or expense.

 

Fair Values of Derivative Instruments in the Statement of Financial Position
    Liability Derivatives
As of June 30 2012
  Derivatives not designated as hedging instruments under ASU 815 Balance Sheet Location Fair Value
  Interest Rate Contracts Accrued Liabilities $                                             (5,000)
       

 

 

The Effect of Derivative Instruments on the Statement of Financial Performance
for the 3 month      
period ending June 30 2012
  Derivatives not Designated as Hedging Instruments under ASU 815 Location of Gain (Loss) Recognized in Income on Derivative Amount of Gain (Loss) Recognized in Income on Derivative
  Interest Rate Contracts Interest Expense  $                              *  (16,000)
*Includes interest of $20,000 associated with variances between fixed and variable rates.
         

 

for the 6 month      
period ending June 30 2012
  Derivatives not Designated as Hedging Instruments under ASU 815 Location of Gain (Loss) Recognized in Income on Derivative Amount of Gain (Loss) Recognized in Income on Derivative
  Interest Rate Contracts Interest Expense  $                              *  (51,000)
*Includes interest of $39,000 associated with variances between fixed and variable rates.